Pear Med, LLC – Trademark Portfolio

Entity Type: 16

Pear Med, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PEARMED. The owner is based in Valley Stream, NY.

811 Wilson Street

Valley Stream, NY 11581

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PEARMED
PEARMED
Registered 2025
PEARMED
PEARMED
Registered 2023
PEARMED
PEARMED
Registered 2023

Trademark Classifications

Pear Med, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Pear Med, LLC have?

Pear Med, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Pear Med, LLC file in?

Pear Med, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.

What are Pear Med, LLC's most well-known trademarks?

Pear Med, LLC's registered trademark portfolio includes well-known marks such as PEARMED. These are among 3 currently registered trademarks in the portfolio.

What is Pear Med, LLC's trademark registration success rate?

Pear Med, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.